RTG-LP 10 MG

Retatrutide is a synthetic acylated peptide acting as a triple agonist at the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR). This tri-receptor mechanism distinguishes Retatrutide from first- and second-generation incretin-based research compounds, which target only one or two of these pathways. The simultaneous engagement of all three receptors has generated significant scientific interest, particularly in preclinical models examining energy expenditure modulation, insulin sensitivity signaling, lipid metabolism, and adipose tissue regulation. The addition of glucagon receptor agonism — absent in GLP-1/GIP dual agonists — is hypothesized to drive greater increases in basal energy expenditure and further differentiate the metabolic profile of this compound in research settings. Signal Labs Retatrutide is independently third-party tested for identity, purity, and sequence integrity on every batch.

• Purity: ≥98% (HPLC verified)
• Form: Lyophilized powder
• Quantity: 10mg per vial
• Storage: Store at -20°C. Protect from light and moisture.
• CAS Number: 2381281-05-4

For research use only. Not for human consumption. COA available upon request.